Skip to content

Acute Effects of Caffeinated and Decaffeinated Coffee on Bioelectrical Impedance Analysis

Investigating the Acute Impacts of Caffeinated Coffee, Decaffeinated Coffee, and Water on Body Composition Parameters Measured Via Bioelectrical Impedance Analysis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06754748
Enrollment
28
Registered
2025-01-01
Start date
2023-02-25
Completion date
2023-05-20
Last updated
2025-01-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Composition Measurement

Keywords

Bioelectrical Impedance Analysis, Caffeine, Hydration, Body Composition

Brief summary

This study investigates how caffeinated coffee, decaffeinated coffee, and water affect body composition, as measured by BIA. Participants were divided into three groups, consuming their respective beverages, with measurements taken over a 120-minute period. The study aimed to determine if caffeine or fluid intake is the primary driver of changes in body composition parameters.

Detailed description

This study aims to address these gaps by examining how caffeinated coffee, decaffeinated coffee, and water influence BIA measurements at multiple intervals post-consumption (baseline, 30, 60, 90, and 120 minutes). By incorporating a controlled study design with separate water-only and caffeine-free groups, this methodology overcomes the limitations of previous studies that lacked comprehensive control conditions. By determining whether caffeine or fluid volume primarily drives changes in BIA parameters and identifying the timing of these effects, this research seeks to improve the understanding of external factors affecting BIA, providing valuable insights for accurate body composition assessments. Participants were divided into three groups based on their average daily caffeine consumption: caffeinated coffee, decaffeinated coffee, and water. To standardize caffeine and fluid intake, filter coffee was chosen for its consistency in caffeine content and fluid volume. Both caffeinated and decaffeinated Arabic coffee were prepared using 11 g of coffee per 200 ml of water. The coffee was weighed using a precision balance and brewed with a filter coffee machine to ensure uniform preparation. Participants were instructed to adhere to the following restrictions prior to the analysis day: a 12-hour fast, avoidance of excessive fluids, abstinence from caffeine-containing beverages, no showering or sauna use, no alcohol consumption for 48 hours, and no heavy exercise for 4-12 hours before the measurement. These restrictions minimized potential confounding effects on hydration or metabolic state, ensuring reliable BIA measurements. The first BIA measurements were taken before any beverage consumption. Subsequently, participants consumed 200 ml of caffeinated coffee, decaffeinated coffee, or water, depending on their group. BIA measurements were repeated at 30, 60, 90, and 120 minutes post-consumption.

Interventions

11 g caffeinated coffee made with 200 ml water was given to participants.

11 g decaffeinated coffee made with 200 ml water was given to participants.

OTHERWater

200 ml water was given to participants.

Sponsors

Marmara University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults aged ≥18 years. * BMI between 18.5 and 29.9 kg/m². * Regular coffee consumers. * Participants providing written informed consent.

Exclusion criteria

* Individuals on medication or hormone therapy within the last 6 months. * Medical conditions affecting caffeine metabolism (e.g., allergies or intolerances). * Chronic or acute diseases. * Significant appetite or eating disturbances in the past 6 months. * Participants menstruating on the day of analysis.

Design outcomes

Primary

MeasureTime frameDescription
Change in body fat percentageBaseline and 30, 60, 90, and 120 minutes.BIA measurements were recorded for the body fat percentage (%) at baseline, 30, 60, 90, and 120 minutes.
Change in muscle massBaseline and 30, 60, 90, and 120 minutes.BIA measurements were recorded for the muscle mass (kg) at baseline, 30, 60, 90, and 120 minutes.
Change in total body waterBaseline and 30, 60, 90, and 120 minutes.BIA measurements were recorded for the total body water (kg) at baseline, 30, 60, 90, and 120 minutes.
Change in Body Fat MassBaseline, 30, 60, 90 and 120 minutesBIA measurements were recorded for the body fat mass (kg) at baseline, 30, 60, 90, and 120 minutes.
Change in fat-free massBaseline and 30, 60, 90, and 120 minutes.BIA measurements were recorded for the fat-free mass (kg) at baseline, 30, 60, 90, and 120 minutes.

Secondary

MeasureTime frameDescription
Change in Body Mass IndexBaseline, 30, 60, 90 and 120 minutesBody mass index was calculated from weight and height and presented as kg/m² at baseline, 30, 60, 90 and 120 minutes and recorded.
Change in Body WeightBaseline, 30, 60, 90 and 120 minutesBody weight (kg) was measured with BIA at baseline, 30, 60, 90 and 120 minutes and recorded.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026